{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:47:02Z","timestamp":1791316022189,"version":"4.3.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1992,2,1]],"date-time":"1992-02-01T00:00:00Z","timestamp":696902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1992,2]]},"DOI":"10.1007\/bf00278469","type":"journal-article","created":{"date-parts":[[2004,10,3]],"date-time":"2004-10-03T17:52:03Z","timestamp":1096825923000},"page":"121-125","source":"Crossref","is-referenced-by-count":100,"title":["The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"42","author":[{"given":"T. S.","family":"Tracy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Krohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. D.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. C.","family":"Brater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.7326\/0003-4819-107-2-418","volume":"107","author":"Health and Public Policy Committee, American College of Physicians","year":"1987","unstructured":"Health and Public Policy Committee, American College of Physicians (1987) Methotrexate in rheumatoid arthritis. Ann Intern Med 107: 418?419","journal-title":"Ann Intern Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.1780310301","volume":"31","author":"DE Furst","year":"1988","unstructured":"Furst DE, Kremer JM (1988) Methotrexate in rheumatoid arthritis. Arth Rheum 31: 305?314","journal-title":"Arth Rheum"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7326\/0003-4819-107-2-358","volume":"107","author":"P Tugwell","year":"1987","unstructured":"Tugwell P, Bennett K, Gent M (1987) Methotrexate in rheumatoid arthritis: indications, contraindications, efficacy and safety. Ann Intern Med 107: 358?366","journal-title":"Ann Intern Med"},{"key":"CR4","unstructured":"Hall S, Buchbinder R, Harkness A, Littlejohn G, Miller M, Ryan P (1988) Safety and efficacy of low dosage long term methotrexate in rheumatoid arthritis assessed by lifetable analysis of treatment terminations (abstract). Arth Rheum 31 [Suppl]: S116"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/art.1780310203","volume":"31","author":"ME Weinblatt","year":"1988","unstructured":"Weinblatt ME, Trentham DE, Fraser PA, Holdworth DE, Falcheck KR, Weissman BN, Coblyn JS (1988) Long term prospective trial of low dose methotrexate in rheumatoid arthritis. Arth Rheum 31: 167?175","journal-title":"Arth Rheum"},{"key":"CR6","first-page":"313","volume":"16","author":"DE Furst","year":"1989","unstructured":"Furst DE, Koehnke R, Burmeister LF, Kohler J, Cargill I (1989) Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J Rheumatol 16: 313?320","journal-title":"J Rheumatol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/clpt.1990.69","volume":"47","author":"CF Stewart","year":"1990","unstructured":"Stewart CF, Fleming RA, Arkin CR, Evans WE (1990) Coad-ministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis. Clin Pharmacol Ther 47: 540?546","journal-title":"Clin Pharmacol Ther"},{"key":"CR8","first-page":"1","volume":"226","author":"DW Nierenberg","year":"1983","unstructured":"Nierenberg DW (1983) Competitive inhibition of methotrexate in rabbit kidney slices by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 226: 1?6","journal-title":"J Pharmacol Exp Ther"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/art.1780330620","volume":"33","author":"B Nuernberg","year":"1990","unstructured":"Nuernberg B, Koehnke R, Solsky M, Hoffman J, Furst DE (1990) Biliary elimination of low-dose methotrexate in humans. Arth Rheum 1990; 33: 898?902","journal-title":"Arth Rheum"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/bjc.1973.190","volume":"28","author":"PJ Creaven","year":"1973","unstructured":"Creaven PJ, Hansen HH, Alford DA, Allen LM (1973) Methotrexate in liver and bile after intravenous dosage in man. Br J Canc 28: 589?591","journal-title":"Br J Canc"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/cpt1969106849","volume":"10","author":"DG Liegler","year":"1969","unstructured":"Liegler DG, Henderson ES, Hahn MA, Oliverio VT (1969) The effect of organic acids on renal clearance of methotrexate in man. Clin Pharmacol Ther 10: 849?857","journal-title":"Clin Pharmacol Ther"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/jps.2600790907","volume":"79","author":"D Furst","year":"1990","unstructured":"Furst D, Herman R, Koehnke R, Ericksen N, Hash L, Riggs CE, Porras A, Veng-Pedersen P (1990) The effect of aspirin and sulindac on methotrexate clearance. J Pharm Sci 79: 782?786","journal-title":"J Pharm Sci"},{"key":"CR13","first-page":"1008","volume":"17","author":"KJ Skeith","year":"1990","unstructured":"Skeith KJ, Russell AS, Jamali F, Coates J (1990) Lack of significant interaction between low-dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis. J Rheumatol 17: 1008?1010","journal-title":"J Rheumatol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0140-6736(86)91707-1","volume":"I","author":"RR Singh","year":"1986","unstructured":"Singh RR, Malaviya AN, Pandey JN, Guleria JS (1986) Fatal interaction between methotrexate and naproxen. Lancet I: 1390","journal-title":"Lancet"},{"key":"CR15","first-page":"559","volume":"I","author":"H Daly","year":"1986","unstructured":"Daly H, Boyle J, Roberts C, Scott G (1986) Interaction between methotrexate and nonsteroidal anti-inflammatory drugs. Lancet I: 559","journal-title":"Lancet"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0049-0172(85)90029-0","volume":"15","author":"SK MacKinnon","year":"1985","unstructured":"MacKinnon SK, Starkebaum G, Willkens RF (1985) Pancytopenia associated with low-dose pulse methotrexate in the treatment of rheumatoid arthritis. Semin Arth Rheum 15: 119?136","journal-title":"Semin Arth Rheum"},{"key":"CR17","first-page":"138","volume":"47","author":"TS Tracy","year":"1990","unstructured":"Tracy TS, Jones DR, Hall SD, Brater DC, Bradley JD, Krohn K (1990) The effect of NSAIDs on methotrexate disposition in patients with rheumatoid arthritis. Clin Pharmacol Ther 47: 138","journal-title":"Clin Pharmacol Ther"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arth Rheum 31: 315?324","journal-title":"Arth Rheum"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF00548590","volume":"19","author":"TE Sand","year":"1981","unstructured":"Sand TE, Jacobsen S (1981) Effect of urine pH and flow on renal clearance of methotrexate. Eur J Clin Pharmacol 19: 453?456","journal-title":"Eur J Clin Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF01062108","volume":"6","author":"WL Chiou","year":"1978","unstructured":"Chiou WL (1978) Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule for the calculation of the area under the plasma concentration time curve. J Pharmacokinet Biopharm 6: 539?546","journal-title":"J Pharmacokinet Biopharm"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/01621459.1975.10479871","volume":"70","author":"I Einot","year":"1975","unstructured":"Einot I, Gabriel KR (1975) A study of the powers of several methods of multiple comparisons. J Am Stat Assoc 70: 351","journal-title":"J Am Stat Assoc"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0002-9343(84)80017-0","volume":"71A","author":"KS Albert","year":"1984","unstructured":"Albert KS, Gernaat CM (1984) Pharmacokinetics of ibuprofen. Am J Med 71A: 40?46","journal-title":"Am J Med"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/cpt1974153261","volume":"15","author":"RA Runkel","year":"1974","unstructured":"Runkel RA, Forchielli E, Sevelius H, Chaplin M, Segre E (1974) Nonlinear plasma level response to high doses of naproxen. Clin Pharmacol Ther 15: 261?266","journal-title":"Clin Pharmacol Ther"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00561662","volume":"9","author":"W Wosilait","year":"1976","unstructured":"Wosilait W (1976) Theoretical analysis of the binding of salicylate by human serum albumin. The relationship between free and bound drug and therapeutic levels. Eur J Clin Pharmacol 9: 285?290","journal-title":"Eur J Clin Pharmacol"},{"key":"CR25","first-page":"36","volume-title":"Drug-protein binding","author":"I Sjoholm","year":"1986","unstructured":"Sjoholm I (1986) The specificity of drug binding sites on human serum albumin. In: Reidenberg MM, Erill S (eds) Drug-protein binding, Praeger Scientific, New York, pp 36?44"},{"key":"CR26","first-page":"1052","volume":"12","author":"G Sudlow","year":"1976","unstructured":"Sudlow G, Birkett DJ, Wade DN (1976) Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 12: 1052?1061","journal-title":"Mol Pharmacol"},{"key":"CR27","first-page":"263","volume":"232","author":"SD Hall","year":"1985","unstructured":"Hall SD, Rowland M (1985) Influence of fraction unbound upon the renal clearance of furosemide in the isolated perfused rat kidney. J Pharmacol Exp Ther 232: 263?268","journal-title":"J Pharmacol Exp Ther"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/03009747309097093","volume":"2","author":"R Runkel","year":"1973","unstructured":"Runkel R, Forchielli E, Boost G, Chaplin M, Hill R, Sevelius H, Thompson G, Segre E (1973) Naproxen metabolism, excretion and comparative pharmacokinetics. Scand J Rheum [Suppl] 2: 29?36","journal-title":"Scand J Rheum"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/cpt1972132258","volume":"13","author":"G Levy","year":"1972","unstructured":"Levy G, Tsuchiya T, Amsel LP (1972) Limited capacity of salicylphenolic glucuronide formation and its effects on the kinetics of salicylate elimination in man. Clin Pharmacol Ther 13: 258?268","journal-title":"Clin Pharmacol Ther"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/jps.2600671110","volume":"67","author":"PA Koch","year":"1978","unstructured":"Koch PA, Schultz CA, Wills RJ, Hallquist SL, Welling PG (1978) Influence of food and fluid ingestion on aspirin bioavailability. J Pharm Sci 67: 1533?1535","journal-title":"J Pharm Sci"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jps.2600780219","volume":"78","author":"RA Herman","year":"1989","unstructured":"Herman RA, Veng-Pedersen P, Hoffman J, Koehnke R, Furst DE (1989) Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients. J Pharm Sci 78: 165?171","journal-title":"J Pharm Sci"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00278469.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00278469\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00278469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T18:27:19Z","timestamp":1554316039000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00278469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992,2]]}},"alternative-id":["BF00278469"],"URL":"https:\/\/doi.org\/10.1007\/bf00278469","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,2]]}}}